Quick Takeaways
- FMR LLC filed SCHEDULE 13G/A for NEUMORA THERAPEUTICS INC COMMON STOCK (NMRA).
- Disclosed ownership: 2.2%.
- Date of event: 31 Mar 2025.
FMR LLC - 31 Mar 2025 SCHEDULE 13G/A Report for NEUMORA THERAPEUTICS INC COMMON STOCK (NMRA)
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Symbol
- NMRA
- Shares outstanding
- 158,923,455 shares
- Disclosed Ownership
- 3,496,316 shares
- Ownership
- 2.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 May 2025, 10:36:17 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 2.2% ownership in NEUMORA THERAPEUTICS INC COMMON STOCK (NMRA) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 May 2025, 10:36.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 2.2% | 3,496,316 | 3,491,135 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 2.2% | 3,496,316 | 0 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** |